The Centers for Medicare & Medicaid Services yesterday announced proposed changes to the Medicare Advantage and Part D prescription drug programs for calendar year 2018, which would increase payment rates by a net 0.25%. When combined with expected growth in plan risk scores, CMS anticipates the MA plans and Part D sponsors will see an average revenue increase of 2.75%. CMS proposes to use the same proportion of Risk Adjustment Processing System and encounter data for purposes of calculating risk adjustment as was used in 2017 and apply the minimum coding intensity adjustment allowable under federal law. CMS also proposes several changes to the Medicare Advantage Star Ratings program, the service category cost-sharing requirements, and the drug utilization review controls. CMS will accept comments on the 2018 Advance Notice and Draft Call Letter through March 3, and expects to publish a final rate announcement and call letter on April 3. 

Related News Articles

Headline
The departments of Health and Human Services and the Treasury today approved a Section 1332 waiver for Oregon to implement a five-year reinsurance…
Headline
President Trump today issued an executive order directing the departments of Treasury, Labor and Health and Human Services to consider proposing regulations or…
Headline
Baxter Healthcare Corp., in coordination with the Food and Drug Administration, has agreed to temporarily import certain intravenous drug products, such…
Headline
President Trump yesterday named Eric Hargan as Acting Secretary of Health and Human Services. Confirmed as HHS deputy secretary last week, Hargan previously…
Headline
Hospitals generally support the proposed cancellation of the cardiac and Surgical Hip and Femur Fracture Treatment bundling program and Comprehensive Care for…
Headline
Twenty-three organizations, including the AHA, Friday urged the Centers for Medicare & Medicaid Services to suspend implementation of new draft Medicare…